Navigation Links
Formedix Releases Transform for OpenClinica to Drive Efficiencies in Clinical Trials
Date:11/19/2013

>Your Clinical Trials Automated. Everywhere.

About OpenClinica

OpenClinica, LLC is the global leader in open source EDC | CDMS software with thousands of implementations at contract research organizations, biopharmaceutical companies, academic, and government organizations. The powerful tools and superior quality system increase the speed of data collection and ensure data integrity in clinical trials. OpenClinica supports ICH, GCP, 21 CFR Part 11, HIPAA, and other regulatory guidelines, and is designed as a standards-based, extensible, and modular platform.

For more information visit https://www.openclinica.com.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11349062.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. "Collaborate to Innovate" with Formedix at DIA Annual Meeting 2012
2. Formedix Partners with Perceptive Informatics for Forthcoming Webcast, “Four Secrets to Using CDISC Standards to Enable Clinical Trial Efficiencies”
3. Formedix to Host Webinar: Discover Define-XML - Practical Uses Today and a Technical Deep Dive on March 14, 2013
4. Formedix and OmniComm Partner to Offer CRO and Sponsors Multi-Vendor EDC Capabilities
5. Formedix to Host Executive Breakfast prior to Bay Area CDISC Network Meeting, May 23, 2013
6. Take a Standards Health Check with Formedix at DIA 49th Annual Meeting
7. Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston
8. Formedix Partners With OpenClinica to Deliver Automated End-to-End Clinical Trial Builds
9. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
10. HCCS Releases ICD-10 Countdown Clock With Integrated CMS Twitter Tweets
11. eCareSoft Releases eCS Cirrus™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 26, 2015 S&P Capital IQ (MHFI) announced ... coverage on MabVax Therapeutics Holdings Inc . ... stage biotechnology company focused on the development of vaccine ... the treatment of cancer. MabVax has discovered a pipeline ... immune responses generated by patients who have been immunized ...
(Date:2/26/2015)... 26, 2015  23andMe, the leading personal genetics company, ... as Privacy Officer and Corporate Counsel. Black brings a ... as well as health care regulations. As a member ... responsible for reviewing, updating and enhancing the company,s privacy ... abroad. She joined the company January 5, 2015 and ...
(Date:2/26/2015)... Synageva BioPharma Corp. (NASDAQ: GEVA ... rare disorders, today reported 2014 full year financial ... and financial guidance.  Synageva,s management team will host ... to review the financial results and provide a ... by telephone, please dial (877) 445-4603 for U.S. ...
(Date:2/26/2015)... PARK, Calif. , Feb. 26, 2015 ... released the latest version of the Governance Portal ... accomplish governance, risk and compliance (GRC) tasks across multiple ... also been updated to help customers better align their ... of the Treadway Commission ) requirements. In response to ...
Breaking Biology Technology:S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 523andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3
... Bio Inc. (ORC) a biotech company developing stem ... with the European Competent Authority in Seville, Spain, ... HYC750 in healthy male volunteers. The goal of ... pharmacokinetics and pharmacodynamics (induction of hematopoiesis) of HYC750, ...
... SHENYANG, China, Feb. 9 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc.,(Nasdaq: ... focused on researching,developing, manufacturing and marketing biopharmaceutical products ... Mr. Bo Tan as Chief Financial,Officer, effective February ... Mr.,Tan has been acting as the financial advisor ...
... DUBLIN, Ireland, February 9, Shire plc (LSE: SHP, NASDAQ: ... IV Notice letters from Barr Laboratories, Inc.,("Barr) and Mylan, ... in each case of the filing of an Abbreviated ... 750mg and 1gm FOSRENOL(R),(lanthanum carbonate). , ...
Cached Biology Technology:Orcrist Bio Inc. Files with European Competent Authority for a Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750 2Orcrist Bio Inc. Files with European Competent Authority for a Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750 33SBio Inc. Appoints Mr. Bo Tan as Chief Financial Officer 2Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan 2
(Date:2/23/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD and ... focused on the growing mobile commerce market, announced today ... DISTRIBUTED VOICE DIRECTED PAYMENT METHOD AND SYSTEM. ... payment method. Payment accounts may be selected via voice ... if both the speech (the word associated with the ...
(Date:2/12/2015)... Minn. , Feb. 12, 2015   ... company specializing in clinical study management systems, has ... Program , further distinguishing iMedNet ... Clinical Research Organizations (CROs) and healthcare consultants.  Building ... support, prospective customer referrals and numerous co-marketing opportunities), ...
(Date:2/9/2015)... , Feb. 9, 2015  Lintec of America ... methods for carbon nanotube (CNT) macrostructures, including sheets, yarns ... Dallas (UTD). Leveraging the vast industrial resources ... Tokyo, Japan , Lintec of America is forming ... Richardson, TX , focusing on scaling up the ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... and doctors from universities and industries around the ... project announced Sept. 4 to develop implantable devices ... designed to adapt to physical changes in a ... Naturally dissolving plates, screws, stents, and other devices ...
... 2008 As the anniversary of the September 11 ... a new podcast describing an array of technologies to ... podcast is the sixth episode in ACS,s acclaimed ... twice monthly, Global Challenges examines daunting problems facing society ...
... a gene enhancer, known as HACNS1, that may have contributed ... possibly also modifications in the ankle or foot that allow ... published in Science on Sept. 5, 2008. ... existence of human-specific gene enhancers, which are switches near genes ...
Cached Biology News:Project aims to reduce complications, multiple surgeries with biodegradable implantable devices 2Project aims to reduce complications, multiple surgeries with biodegradable implantable devices 3Project aims to reduce complications, multiple surgeries with biodegradable implantable devices 4New 'chemical radar' among national security innovations in ACS podcast 2New 'chemical radar' among national security innovations in ACS podcast 3Gene enhancer in evolution of human opposable thumb 2Gene enhancer in evolution of human opposable thumb 3
Chicken polyclonal antibody to Glutathione-S-Transfrease (GST)...
... BODIPY FL ATP-Gamma-S binds to ... nucleotide the BODIPY FL fluorophore was ... In addition to its potential use ... ATP-Gamma-S thioether is an important new ...
... the industry standard microarray image analysis software ... and analysis tools, visualizations, automation capabilities, performance ... included with every GenePix scanner, and it ... and all types of arrays. A wide ...
... Simplify the process and you reduce the ... into the CEQ 8000. Developed using Beckman ... leadership in capillary electrophoresis technology, the CEQ ... system. This system automatically fills the capillary ...
Biology Products: